Correction: The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.

Correction: The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.

Bibliographic Details
Main Authors:	Sheng Guo, Chengying Yang, Bo Diao, Xiaoyong Huang, Meihua Jin, Lili Chen, Weiming Yan, Qin Ning, Lixin Zheng, Yuzhang Wu, Yongwen Chen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-10-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC4599911?pdf=render

Similar Items

The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.
by: Sheng Guo, et al.
Published: (2015-09-01)

Correction: The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.
by: PLOS Pathogens Staff
Published: (2016-02-01)

Diverse viral proteases activate the NLRP1 inflammasome
by: Brian V Tsu, et al.
Published: (2021-01-01)

Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A
by: Husain Syed A, et al.
Published: (2011-05-01)

Еxpression of cerebral endothelial NLRP3 inflammasome in viral inflammation in vitro
by: A. B. Salmina, et al.
Published: (2018-01-01)

The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
by: Rongrong Bai, et al.
Published: (2021-05-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
by: Shyam S. Chaurasia, et al.
Published: (2018-02-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
by: Jialin Li, et al.
Published: (2017-11-01)

Vitamin D and the NLRP3 Inflammasome
by: Matthew Tunbridge, et al.
Published: (2020-11-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)

Role of the NLRP3 inflammasome in cancer
by: Maryam Moossavi, et al.
Published: (2018-11-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
by: Ayesha Zahid, et al.
Published: (2019-10-01)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018-09-01)

NLRP3 Inflammasome and Inflammatory Diseases
by: Zheng Wang, et al.
Published: (2020-01-01)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011-03-01)

NLRP3 Inflammasome and Pathobiology in AMD
by: Lucia Celkova, et al.
Published: (2015-01-01)

NLRP3 Inflammasome and MS/EAE
by: Makoto Inoue, et al.
Published: (2013-01-01)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021-03-01)

RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly
by: Yanhui Duan, et al.
Published: (2020-11-01)

Activation of NLRP1 inflammasome is triggered by Clostridium difficile
by: Liang-KueiChen, et al.
Published: (2017)

Inflammasome : Investigating the effect of NEK7 in the activation of the NLRP3 Inflammasome
by: Adindu Uzowuru, Cosmas
Published: (2020)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
by: Ge Zhang, et al.
Published: (2021-06-01)

NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
by: Hui-Chen Guo, et al.
Published: (2015-06-01)

Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3
by: Yangliu Xia, et al.
Published: (2021-02-01)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
by: Magdalena Ciążyńska, et al.
Published: (2021-05-01)

Regulation of NLRP3 inflammasome activation by mitochondria
by: Elliott, Eric Isaac
Published: (2018)

THE DEVELOPMENT OF NOVEL INHIBITORS OF THE NLRP3 INFLAMMASOME
by: Fulp, Jacob W
Published: (2018)

The Role of PKC on NLRP3 Inflammasome Activation
by: Bo-Chang Su, et al.
Published: (2014)

Role of the NLRP3 inflammasome in autoimmune diseases
by: Zhe Li, et al.
Published: (2020-10-01)

Dicer regulates activation of the NLRP3 inflammasome.
by: David M Ojcius, et al.
Published: (2019-01-01)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
by: Eleonora Mezzaroma, et al.
Published: (2021-02-01)

Targeting the NLRP3 Inflammasome via BTK
by: Alexander N. R. Weber, et al.
Published: (2021-02-01)

Focus on the Role of NLRP3 Inflammasome in Diseases
by: Roberta Fusco, et al.
Published: (2020-06-01)

The Role of NLRP3 Inflammasome in Pneumococcal Infections
by: Surabhi Surabhi, et al.
Published: (2020-12-01)

The NLRP1 Inflammasome in Human Skin and Beyond
by: Gabriele Fenini, et al.
Published: (2020-07-01)

Regulation of NLRP3 inflammasome: Biochemistry and beyond
by: Buelvas Jiménez, Neudo, et al.
Published: (2015-04-01)

Cannot write session to /tmp/vufind_sessions/sess_r0c32ot4rmkq0v0d0nudhsdn90